Drugs / Allogeneic adult adipose-derived mesenchymal stem cells
Allogeneic adult adipose-derived mesenchymal stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01649687 | May 2012 → Jan 2014 | cerebellar ataxia | National Yang Ming Chiao Tung University | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Allogeneic adult adipose-derived mesenchymal stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01649687 ↗ |
| Route | Intravenous | “Patients will receive intravenously one dose of 5-7x10\^7 cells of allogeneic adipose-derived mesenchymal stem cells” NCT01649687 ↗ |